Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

Advances in DNA sequencing have made genetic testing fast and affordable, but limitations of testing processes are impeding realisation of patient benefits. Ovarian cancer exemplifies the potential value of genetic testing and the shortcomings of current pathways to access testing. Approximately 15%...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Angela, Riddell, Daniel, Seal, Sheila, Talukdar, Sabrina, Mahamdallie, Shazia, Ruark, Elise, Cloke, Victoria, Slade, Ingrid, Kemp, Zoe, Gore, Martin, Strydom, Ann, Banerjee, Susana, Hanson, Helen, Rahman, Nazneen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942815/
https://www.ncbi.nlm.nih.gov/pubmed/27406733
http://dx.doi.org/10.1038/srep29506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942815/
https://www.ncbi.nlm.nih.gov/pubmed/27406733
http://dx.doi.org/10.1038/srep29506

Ejemplares similares